According to New Atlas, researchers from the University of Pittsburgh have used CRISPR-Cas9, the genome editing system, to target a cancer's "command centre," effectively reducing a tumor by 30% and preventing further growth. It works by delivering new DNA targeting those command genes via a virus and replacing them with a cancer-killing ones.
In the University of Pittsburgh study, the team transplanted human prostate and liver cancer cells into mice, then treated one group with the CRISPR tool that targets those fusion genes. As a result, the tumors shrunk by up to 30 percent, didn't spread through the body, and the animals all survived to the end of the eight-week test. Meanwhile, in a control group that received the same treatment targeting fusion genes that weren't present in their bodies, the tumors grew almost 40 times larger and in most cases, spread to other parts of the body. None of the control group survived to the end of the test period.
|The Psychology of Darth Vader Revealed|
|Chemicals Found in Shampoo and Other Consumer Products Have Never Been Thoroughly Tested and Proved to be Safe|
|Using a Cancer Defence to Defeat It|
|"I see mothers with children, [...] I see kids playing soccer."|
|"There needs to be more aggressive enforcement action on tech companies like Google."|
|How to Avoid Jury Duty|
|Making a Movie Inside a Video Game|
|“Not a single personal insult was uttered by any member of the crew.”|
|"Cells have the capacity to process and respond to instructions and codes inputted into their main system."|
|“Clicking on a Facebook advert may reveal things about yourself you don’t want anyone to know.”|
|Google Map Shows You the Most Photographed Areas of the World|
|“Instead of consuming fossil fuels, it would then feed surplus electricity into the grid.”|